Skip to search formSkip to main contentSkip to account menu

McN 5691

Known as: Benzenepropanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-5-methoxy-N,alpha-dimethyl-2-(phenylethynyl)-, McN-5691 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Propylamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Pharmacophore modelling of structurally unusual diltiazem mimics at L-type calcium channels
The purpose of this theoretical study was to investigate the molecular features of some structurally unusual calcium antagonists… 
1998
1998
Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
The excretion and metabolism of a 2-ethynylbenzenealkanamine analog, antihypertensive RWJ-26240 (McN-5691), in beagle dogs was… 
1990
1990
Cardiac Electrophysiologic Effects of McN‐5691, a New Calcium‐Channel Blocking Antihypertensive Agent
Summary The purpose of this study was to evaluate the cardiac electrophysiological effects of McN-5691, a new calcium-channel… 
1988
1988
Effects of the novel calcium channel blocker, McN-5691, on cardiocirculatory dynamics and cardiac output distribution in conscious spontaneously hypertensive rat.
The purpose of this study was to characterize the cardiocirculatory effects of McN-5691 in the conscious spontaneously… 
1986
1986
McN-5691: a novel vasodilator which blocks receptor-operated and potential-dependent calcium channels in rabbit aorta
The mechanism of action of the novel vasodilator McN-5691 (N-(2-(3,4-dimethoxyphenyl)ethyl)-5-methoxy-N,..cap alpha..-dimethyl-2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)